Stock screener

DNTH

Conviction 50HealthcareScan · Thu, Sep 24, 2026

Dianthus Therapeutics, Inc. /DE/ (DNTH) closed at $90.86 (-2.76%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 30, RS Rating 95, -21.6% from its 52-week high, +129.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

DNTH$90.86-2.76%
ResistanceSupportVol 14Insider sell
63 bars
12
9
3
Vol MA14 1.02M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Dianthus Therapeutics, Inc. /DE/PHARMACEUTICAL PREPARATIONSwww.dianthustx.com ↗
Price90.86
Change-2.76%
Gap-0.04%
Rel volume1.64×
Avg volume861.02K
Avg $ vol87.27M
SMA 20103.47
SMA 50106.44
SMA 20079.79
Price vs 50-14.64%
Price vs 200+13.88%
MA stackmixed
50/200 cross—
Supertrenddown · 108.40
RSI (14)30
MACD hist-1.62
MACD cross—
Stoch %K / %D5 / 15
ADX (14)25
+DI / −DI9 / 29
RSI divergence—
MACD divergenceBullish
ATR %5.87%
ADR %4.95%
52w high115.96
52w low32.92
From 52w high-21.65%
Above 52w low+176.00%
New 52w highNo
SqueezeOff
Bollinger width21.01%
%B-0.08
Donchian pos4.83%
Donchian high112.13
Donchian low89.78
AVWAP (52w high)103.78
vs AVWAP high-12.45%
AVWAP (52w low)76.14
vs AVWAP low+19.34%
OBV trendDown
Chaikin MF (20)-0.36
Today vs 20d1.64×
Avg vol (14d)1.02M
Avg vol (20d)861.02K
Avg $ vol (20d)87.27M
Market cap5.08B
RS Rating95 / 99
RS 3m (vs SPY)-5.27%
RS 6m (vs SPY)-2.69%
RS line new highNo
Trend template5/8
Technical rank50.1
1 week-10.15%
1 month-18.95%
3 months-0.78%
6 months+14.13%
1 year+139.93%
YTD+128.98%
P/E-31.31
P/B4.34
P/S—
P/FCF-39.28
EPS-4.20
Div yield—
ROE-13.85%
ROA-13.38%
Debt/Eq—
Current26.10
EV/EBITDA-28.25
Gross margin—
Net margin—
Rev growth-67.35%
EPS growth-91.05%
Price target142.82
Target upside57.19%
Analyst ratingBuy
Institutional121.68%
Ent. value4.97B
Revenue396K
Net income-50.22M
Gross profit—
Free cash flow-129.37M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out54.67M
Employees92
ListedTue, Sep 12, 2023
Free float50.43M
Float %92.6%
Short interest8.43M
Days to cover15.3d
Short volume46.4%
Squeeze score72 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.90 vs −$0.93
Last surprise+3.2% beat
Setup gradeC
Conviction50 / 100
Pattern quality—
Tech rank50.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance116.01
Support101.99
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jul 7
    1 scan
  2. Breaking out now
    Aug 14
    1 scan

Recent news

Congress activity

Disclosed STOCK Act trades in DNTH

All disclosures →
No recent disclosed trades by Congress in DNTH. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DNTH · open-market 5 sells

InsiderSideShares
Read Simon
Director · Stock Option (Right to Buy) · 2026-08-19
Exercise2.78K
Read Simon
Director · Common Stock · 2026-08-19
Sell2.78K
Read Simon
Director · Common Stock · 2026-08-19
Exercise2.78K
Veness Adam M
SVP, General Counsel and Sec. · Common Stock · 2026-08-13
Exercise15K
Veness Adam M
SVP, General Counsel and Sec. · Stock Option (Right to Buy) · 2026-08-13
Exercise15K
Read Simon
Director · Common Stock · 2026-08-10
Sell831
Read Simon
Director · Common Stock · 2026-08-10
Sell272
Read Simon
Director · Common Stock · 2026-08-10
Sell470
Read Simon
Director · Common Stock · 2026-08-10
Sell397
Read Simon
Director · Stock Option (Right to Buy) · 2026-08-10
Exercise2.78K

SEC filings

EDGAR filings in DNTH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.